Publications by authors named "Luca Quattrini"

Claim this Profile
Î
β-Cyclodextrin nanosponges for the ocular delivery of therapeutic Micro-RNA in a Mouse model of retinitis Pigmentosa: A proof of concept study.
Ilaria Piano, Beatrice Polini, Francesca Corsi, Sara Carpi, Giovanni Petrarolo, Luca Quattrini

Eur J Pharm Biopharm· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Complexing the Marine Sesquiterpene Euplotin C by Means of Cyclodextrin-Based Nanosponges: A Preliminary Investigation.
Alessandra Bertoli, Anthea LoBue, Luca Quattrini, Stefania Sartini, Beatrice Polini

Mar Drugs· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preclinical Development of FA5, a Novel AMP-Activated Protein Kinase (AMPK) Activator as an Innovative Drug for the Management of Bowel Inflammation.
Luca Antonioli, Carolina Pellegrini, Matteo Fornai, Laura Benvenuti, Vanessa D'Antongiovanni, Luca Quattrini

Int J Mol Sci· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oxy-imino saccharidic derivatives as a new structural class of aldose reductase inhibitors endowed with anti-oxidant activity.
Felicia D'Andrea, Stefania Sartini, Ilaria Piano, Matteo Franceschi, Luca Quattrini

J Enzyme Inhib Med Chem· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Aldehyde Dehydrogenases and Prostate Cancer: Shedding Light on Isoform Distribution to Reveal Druggable Target.
Luca Quattrini, Maria Sadiq, Giovanni Petrarolo, Norman J Maitland, Fiona M Frame

Biomedicines· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Imidazo[1,2-]pyridine Derivatives as Aldehyde Dehydrogenase Inhibitors: Novel Chemotypes to Target Glioblastoma Stem Cells.
Luca Quattrini, Edoardo Luigi Maria Gelardi, Vito Coviello, Stefania Sartini, Davide Maria Ferraris

J Med Chem· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Progress in the Field of Aldehyde Dehydrogenase Inhibitors: Novel Imidazo[1,2-]pyridines against the 1A Family.
Luca Quattrini, Edoardo Luigi Maria Gelardi, Giovanni Petrarolo, Giorgia Colombo, Davide Maria Ferraris

ACS Med Chem Lett· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Soyasaponins from Zolfino bean as aldose reductase differential inhibitors.
Francesco Balestri, Marinella De Leo, Carlo Sorce, Mario Cappiello, Luca Quattrini

J Enzyme Inhib Med Chem· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A 2,3-diphenylpyrido[1,2-] pyrimidin-4-one derivative inhibits specific angiogenic factors induced by TNF-α.
Serena Del Turco, Luca Quattrini, Rocchina Colucci, Melania Gaggini, Concettina La Motta

Saudi Pharm J· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis and investigation of polyhydroxylated pyrrolidine derivatives as novel chemotypes showing dual activity as glucosidase and aldose reductase inhibitors.
Lorenzo Guazzelli, Felicia D'Andrea, Stefania Sartini, Francesco Giorgelli, Gianluca Confini, Luca Quattrini

Bioorg Chem· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dual Kit/Aur Inhibitors as Chemosensitizing Agents for the Treatment of Melanoma: Design, Synthesis, Docking Studies and Functional Investigation.
Luca Quattrini, Vito Coviello, Stefania Sartini, Teresa Di Desidero, Paola Orlandi

Sci Rep· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Aldose reductase inhibitors: 2013-present.
Luca Quattrini, Concettina La Motta

Expert Opin Ther Pat· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antineoplastic Effect of Lenvatinib and Vandetanib in Primary Anaplastic Thyroid Cancer Cells Obtained From Biopsy or Fine Needle Aspiration.
Silvia Martina Ferrari, Concettina La Motta, Giusy Elia, Francesca Ragusa, Ilaria Ruffilli, Luca Quattrini

Front Endocrinol (Lausanne)· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Acid Derivatives of Pyrazolo[1,5-a]pyrimidine as Aldose Reductase Differential Inhibitors.
Francesco Balestri, Luca Quattrini, Vito Coviello, Stefania Sartini, Federico Da Settimo

Cell Chem Biol· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Challenging clinically unresponsive medullary thyroid cancer: Discovery and pharmacological activity of novel RET inhibitors.
Valeria La Pietra, Stefania Sartini, Lorenzo Botta, Alessandro Antonelli, Silvia Martina Ferrari, Luca Quattrini

Eur J Med Chem· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel quinazolinone-based 2,4-thiazolidinedione-3-acetic acid derivatives as potent aldose reductase inhibitors.
Kamel Metwally, Harris Pratsinis, Dimitris Kletsas, Luca Quattrini, Vito Coviello

Future Med Chem· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quinazolinone-based rhodanine-3-acetic acids as potent aldose reductase inhibitors: Synthesis, functional evaluation and molecular modeling study.
Sherihan El-Sayed, Kamel Metwally, Abdalla A El-Shanawani, Lobna M Abdel-Aziz, Ahmed A El-Rashedy, Luca Quattrini

Bioorg Med Chem Lett· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cyclodextrin-based nanosponges for the targeted delivery of the anti-restenotic agent DB103: A novel opportunity for the local therapy of vessels wall subjected to percutaneous intervention.
Vito Coviello, Stefania Sartini, Luca Quattrini, Cecilia Baraldi, Maria Cristina Gamberini

Eur J Pharm Biopharm· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
1
1,2-Benzisothiazole Derivatives Bearing 4-, 5-, or 6-Alkyl/arylcarboxamide Moieties Inhibit Carbonic Anhydrase Isoform IX (CAIX) and Cell Proliferation under Hypoxic Conditions.
Vito Coviello, Beatrice Marchi, Stefania Sartini, Luca Quattrini, Anna Maria Marini

J Med Chem· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis